MedTrace Logo

Antimullerian Hormone Versus Antral Follicle Count for Determination of Gonadotrophin Dosing in IVF

NCT02739269 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-02-27

Study results available
· View outcomes & findings →

Summary

This is a prospective randomized trial to compare the use of AFC and serum AMH as the basis for gonadotrophin dosing in in-vitro fertilization treatment.

The hypothesis is that the use of serum AMH as the criterion for determination of gonadotrophin dosing in IVF treatment results in more optimal ovarian response than AFC.

Conditions

Interventions

OTHER

Serum AMH measurement

Serum AMH is measured one month before the IVF treatment

OTHER

AFC measurement

Early follicular phase AFC is measured one month before the IVF treatment

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Hang Wun Raymond Li, MBBS, FRCOG · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-07
Primary Completion
2018-04-20
Completion
2018-04-20

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02739269 on ClinicalTrials.gov